Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VVZ-149 (Opiranserin) for Post-Operative Pain in Abdominoplasty
NCT03997838Phase 3Completed
- Sponsor
- Vivozon
- Start
- May 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing VVZ-149 Injections with Placebo (2 arms). Primary endpoint: Total Area Under the Curve (AUC) of Pain Intensity for 12 hours post-emergence. Started May 2019; status: completed.
02
Drugs
opiranserin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03997838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03997838.